Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Expert Market

PBIOPressure BioSciences, Inc.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About Pressure BioSciences, Inc. (PBIO)

Pressure BioSciences, Inc. (PBIO) is a Medical Devices company headquartered in Canton, MA, United States whose shares trade over-the-counter on the Expert Market tier.

Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed nearly 300 PCT systems in approximately 175 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.

Products and services

PBI is a manufacturer and distributor of high-pressure equipment and consumables, as well as a distributor of eco-friendly agrochemical products.

PBIO key facts

Ticker symbol
PBIO
Market tier
Expert Market
Headquarters
Canton, MA, United States
Country of incorporation
US
Year of incorporation
2004
Employees
16
Estimated market cap
$219.1K (as of Apr 15, 2025)
Shares outstanding
42,967,084
Reporting standard
U.S. Reporting: SEC Reporting
Audit status
Audited
Fiscal year end
12/31

Pressure BioSciences, Inc. leadership

  • Richard T. Schumacher — CEO, President
  • Edmund Ting — Senior VP, Engineering
  • Alexander Lazarev — Chief Scientific Officer
  • Candice J Schumacher — Controller

Explore more: Medical Devices stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with P

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for Pressure BioSciences, Inc. (PBIO) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Investor Relations Email
Not provided
Headquarters Address
440 Neponset Street
Canton, MA, 02021
United States

Company Leadership

Company Officers

Richard T. Schumacher
CEO, President
Edmund Ting
Senior VP, Engineering
Alexander Lazarev
Chief Scientific Officer
Candice J Schumacher
Controller

Social Media

Business Details

Stock Details

Loading modules...